These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Assessment of the feasibility of oral controlled release in an exploratory development setting. Thombre AG Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208 [TBL] [Abstract][Full Text] [Related]
25. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system. Möller H; Wirbitzki E Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916 [TBL] [Abstract][Full Text] [Related]
26. [Effect of biopharmaceutical studies on the theory and practice of pharmacy]. Senov PL; Tentsova AI; Azhgikhin IS Farmatsiia; 1971; 20(2):3-8. PubMed ID: 5562910 [No Abstract] [Full Text] [Related]
28. In vitro - in vivo correlation: from theory to applications. Emami J J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187 [TBL] [Abstract][Full Text] [Related]
29. Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance. Lalka D; Feldman H J Pharm Sci; 1974 Nov; 63(11):1812. PubMed ID: 4427254 [No Abstract] [Full Text] [Related]
30. Advantages and disadvantages of reformulation of older drugs. Oosterhuis B; Jonkman JH Clin Pharmacokinet; 1993 Sep; 25(3):165-71. PubMed ID: 7900947 [No Abstract] [Full Text] [Related]
31. [Study on index for formulation optimization of sustained or controlled released dosage forms]. Hong YL; Feng Y; Xu DS Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):15-7. PubMed ID: 16548158 [TBL] [Abstract][Full Text] [Related]
32. [The galenic pharmacy in the development of new drugs]. Delattre L Bull Mem Acad R Med Belg; 2007; 162(1-2):141-7; discussion 148-50. PubMed ID: 17821973 [TBL] [Abstract][Full Text] [Related]
33. [Proposal for a new method of classifying biopharmaceutical factors]. Zácek H; Rehula M Cesk Farm; 1984 Mar; 33(2):79-82. PubMed ID: 6722910 [No Abstract] [Full Text] [Related]
34. Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit. Delmas A; Gordien JB; Bernadou JM; Roudaut M; Gresser A; Malki L; Saux MC; Breilh D J Pharm Biomed Anal; 2009 Jul; 49(5):1213-20. PubMed ID: 19362442 [TBL] [Abstract][Full Text] [Related]
35. [In vitro and in vivo biopharmaceutical evaluation of lorazepam commercial tablets]. Giannone I; Musumeci T; Pecora TM; Puglisi G Clin Ter; 2005; 156(5):197-201. PubMed ID: 16382968 [TBL] [Abstract][Full Text] [Related]
37. [Stability testing of drug substances and preparations, a contribution to drug safety]. Kny L; Stark A Pharmazie; 1983 Oct; 38(10):666-70. PubMed ID: 6657735 [No Abstract] [Full Text] [Related]
38. Theme issue "Solid state and solid dosage forms". Kleinebudde P Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869 [No Abstract] [Full Text] [Related]
39. Particulate matter in parenteral solutions. Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614 [No Abstract] [Full Text] [Related]
40. Continuous intravenous administration of drugs. Paris P; Hans P; Lamy M Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]